Financhill
Sell
31

MNPR Quote, Financials, Valuation and Earnings

Last price:
$30.03
Seasonality move :
-28.14%
Day range:
$30.20 - $34.11
52-week range:
$1.72 - $54.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
32.97x
Volume:
17.8K
Avg. volume:
54.7K
1-year change:
648.18%
Market cap:
$163.1M
Revenue:
--
EPS (TTM):
-$1.99

Earnings Data

Next earnings date for MNPR
Mar 28
2025
Most recent earnings per share
-$0.37
Beat by $0.80
(Nov 8/2024)
Consensus Estimate
-$1.17
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MNPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.53 --
03/28/2025 Q4 -- -- -- -$0.42 --
11/08/2024 Q3 -- -- -$0.37 -$1.17 $0.80
08/09/2024 Q2 -- -- -$0.50 -$0.47 -$0.03
05/09/2024 Q1 -- -- -$0.50 -$0.85 $0.35
03/28/2024 Q4 -- -- -$0.62 -$0.85 $0.23
11/09/2023 Q3 -- -- -$0.69 -$0.95 $0.26
08/11/2023 Q2 -- -- -$0.80 -$0.95 $0.15
05/11/2023 Q1 -- -- -$0.95 -$1.08 $0.13
03/23/2023 Q4 -- -- -$1.15 -$1.03 -$0.13
11/10/2022 Q3 -- -- -$0.95 -$1.08 $0.13
08/11/2022 Q2 -- -- -$1.10 -- --
05/12/2022 Q1 -- -- -$0.95 -- --
03/24/2022 Q4 -- -- -$1.05 -- --
11/12/2021 Q3 -- -- -$1.00 -- --
08/12/2021 Q2 -- -- -$0.85 -- --
05/13/2021 Q1 -- -- -$0.80 -- --
03/25/2021 Q4 -- -- -$0.95 -- --
11/12/2020 Q3 -- -- -$0.75 -- --
08/06/2020 Q2 -- -- -$0.70 -- --
05/07/2020 Q1 -- -- -$0.50 -- --
03/27/2020 Q4 -- -- -$0.57 -- --
09/30/2019 Q3 -- -- -$0.35 -- --
06/30/2019 Q2 -- -- -$0.43 -- --
03/31/2019 Q1 -- -- -$0.66 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.31 -- --
06/30/2018 Q2 -- -- -$0.36 -- --
03/31/2018 Q1 -- -- -$0.42 -- --
12/31/2017 Q4 -- -- -$0.34 -- --
09/30/2017 Q3 -- -- -$7.14 -- --
06/30/2017 Q2 -- -- -$0.28 -- --
03/31/2017 Q1 -- -- -$0.18 -- --

Monopar Therapeutics Earnings Questions

  • How Much did Monopar Therapeutics Generate in Revenue Last Quarter?

    Monopar Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Monopar Therapeutics Beat Earnings Last Quarter?

    Monopar Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$1.17 per share.

  • Is Monopar Therapeutics Profitable?

    Monopar Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Monopar Therapeutics EPS Next Year?

    Monopar Therapeutics's earnings are forecast to decrease from -$3.05 per share to -$1.77 per share next year representing a decrease of -41.86%.

  • When is Monopar Therapeutics's Earnings Date?

    Monopar Therapeutics's next earnings date is March 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Is VUG a Good ETF to Buy?
Is VUG a Good ETF to Buy?

For the last few years, earnings growth from the tech…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
50
TREE alert for Mar 13

LendingTree [TREE] is up 1.53% over the past day.

Buy
57
INOD alert for Mar 13

Innodata [INOD] is down 7.4% over the past day.

Sell
40
VIST alert for Mar 13

Vista Energy SAB de CV [VIST] is up 0.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock